<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="table2" position="float"><object-id pub-id-type="doi">10.7554/eLife.28020.004</object-id><label>Table 2.</label><caption><title>Antiviral activity of GRL-121 and &#8722;142 against cHIV<sub>NL4-3</sub><sup>WT</sup> and two HIV-2 strains and their cytotoxicities in vitro.</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Drug</th><th colspan="3">Mean IC<sub>50</sub>(nM)&#160;&#177;&#160;SD</th><th rowspan="2">CC<sub>50</sub> (&#956;M)</th><th rowspan="2">Selectivity index*</th></tr><tr><th>cHIV<sub>NL4-3</sub><sup>WT</sup></th><th>HIV-2<sub>ROD</sub></th><th>HIV-2<sub>EHO</sub></th></tr></thead><tbody><tr><td>SQV</td><td>12&#160;&#177;&#160;3</td><td>9.0&#160;&#177;&#160;5.0</td><td>8.8&#160;&#177;&#160;2.1</td><td>33</td><td>2750</td></tr><tr><td>IDV</td><td>18&#160;&#177;&#160;5</td><td>31&#160;&#177;&#160;3</td><td>55&#160;&#177;&#160;25</td><td>75</td><td>4167</td></tr><tr><td>NFV</td><td>23&#160;&#177;&#160;5</td><td>27&#160;&#177;&#160;0.4</td><td>84&#160;&#177;&#160;20</td><td>32</td><td>1391</td></tr><tr><td>RTV</td><td>34&#160;&#177;&#160;10</td><td>136&#160;&#177;&#160;165</td><td>278&#160;&#177;&#160;88</td><td>35</td><td>1.029</td></tr><tr><td>TPV</td><td>330&#160;&#177;&#160;13</td><td>293&#160;&#177;&#160;45</td><td>313&#160;&#177;&#160;48</td><td>34</td><td>103</td></tr><tr><td>APV</td><td>26&#160;&#177;&#160;8</td><td>170&#160;&#177;&#160;82</td><td>305&#160;&#177;&#160;78</td><td>&gt;150</td><td>&gt;4167</td></tr><tr><td>LPV</td><td>13&#160;&#177;&#160;8</td><td>40&#160;&#177;&#160;28</td><td>11&#160;&#177;&#160;2</td><td>33</td><td>2538</td></tr><tr><td>ATV</td><td>4.0&#160;&#177;&#160;2.3</td><td>28&#160;&#177;&#160;6</td><td>10&#160;&#177;&#160;8</td><td>80</td><td>20,000</td></tr><tr><td>DRV</td><td>3.2&#160;&#177;&#160;0.7</td><td>8.5&#160;&#177;&#160;0.7</td><td>6.2&#160;&#177;&#160;0.7</td><td>133</td><td>41,562</td></tr><tr><td>GRL-121</td><td>0.26&#160;&#177;&#160;0.05</td><td>0.020&#160;&#177;&#160;0.014</td><td>0.071&#160;&#177;&#160;0.071</td><td>34</td><td>130,769</td></tr><tr><td>GRL-142</td><td>0.019&#160;&#177;&#160;0.017</td><td>0.00032&#160;&#177;&#160;0.00015</td><td>0.000059&#160;&#177;&#160;0.000025</td><td>47</td><td>2,473,684</td></tr></tbody></table><table-wrap-foot><fn><p>*Each selectivity index denotes a ratio of CC<sub>50</sub> to IC<sub>50</sub> against cHIV<sub>NL4-3</sub><sup>WT</sup>.</p><p>The data shown represent mean values (&#177;1 standard deviation) derived from the results of three independent experiments.</p></fn></table-wrap-foot></table-wrap>